Dr Peter Lewis Poses, PHD, LMFT | |
2550 Stover St, E101, Fort Collins, CO 80525-4641 | |
(303) 851-7265 | |
(303) 316-7352 |
Full Name | Dr Peter Lewis Poses |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 2550 Stover St, Fort Collins, Colorado |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073683504 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Dr Peter Lewis Poses, PHD, LMFT 2550 Stover St, E101, Fort Collins, CO 80525-4641 Ph: (303) 851-7265 | Dr Peter Lewis Poses, PHD, LMFT 2550 Stover St, E101, Fort Collins, CO 80525-4641 Ph: (303) 851-7265 |
News Archive
The Norwegian company Curato, the Nordic region's largest provider of radiology examinations, is making a major investment in its mammography operations by investing in Sectra's digital mammography system, Sectra MicroDose Mammography. Curato will thus be able to offer Norwegian women the opportunity to choose mammography with the lowest dose of radiation in the market. The order comprises three mammography stands.
The University of California, Irvine was awarded $1 million by the U.S. Centers for Disease Control and Prevention and Agency for Toxic Substances and Disease Registry to participate in the first year of a major multi-site health study to investigate the relationship between drinking water contaminated with per- and polyfluoroalkyl substances and health outcomes.
Human milk is infant food, but for sick, hospitalized babies, it's also medicine. That's the central premise of a series of articles in a neonatal nursing journal's special issue focused on human milk for sick newborns.
The Australian Breastfeeding Association (ABA) accredited UQ as a breastfeeding friendly organisation after reviewing its breastfeeding facilities and policies.
Millendo Therapeutics, a University of Michigan startup company, announced an exclusive license agreement with AstraZeneca for the worldwide development and commercialization rights to test a new compound, MLE4901, for the treatment of polycystic ovary syndrome.
› Verified 4 days ago